title: Acidic microenvironment and bone pain in cancer-colonized bone.
abstract: Solid cancers and hematologic cancers frequently colonize bone and induce skeletal-related complications. Bone pain is one of the most common complications associated with cancer colonization in bone and a major cause of increased morbidity and diminished quality of life, leading to poor survival in cancer patients. Although the mechanisms responsible for cancer-associated bone pain (CABP) are poorly understood, it is likely that complex interactions among cancer cells, bone cells and peripheral nerve cells contribute to the pathophysiology of CABP. Clinical observations that specific inhibitors of osteoclasts reduce CABP indicate a critical role of osteoclasts. Osteoclasts are proton-secreting cells and acidify extracellular bone microenvironment. Cancer cell-colonized bone also releases proton/lactate to avoid intracellular acidification resulting from increased aerobic glycolysis known as the Warburg effect. Thus, extracellular microenvironment of cancer-colonized bone is acidic. Acidosis is algogenic for nociceptive sensory neurons. The bone is densely innervated by the sensory neurons that express acid-sensing nociceptors. Collectively, CABP is evoked by the activation of these nociceptors on the sensory neurons innervating bone by the acidic extracellular microenvironment created by bone-resorbing osteoclasts and bone-colonizing cancer cells. As current treatments do not satisfactorily control CABP and can elicit serious side effects, new therapeutic interventions are needed to manage CABP. Understanding of the cellular and molecular mechanism by which the acidic extracellular microenvironment is created in cancer-colonized bone and by which the expression and function of the acid-sensing nociceptors on the sensory neurons are regulated would facilitate to develop novel therapeutic approaches for the management of CABP.
authors.affiliation: Department of Medicine, Hematology/Oncology, Indiana University School of Medicine , Indianapolis, IN, USA.
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Yoneda
authors.affiliation: Department of Medicine, Hematology/Oncology, Indiana University School of Medicine , Indianapolis, IN, USA.
authors.forename: Masahiro
authors.initials: M
authors.lastname: Hiasa
authors.affiliation: Department of Medicine, Hematology/Oncology, Indiana University School of Medicine , Indianapolis, IN, USA.
authors.forename: Yuki
authors.initials: Y
authors.lastname: Nagata
authors.affiliation: Department of Medicine, Hematology/Oncology, Indiana University School of Medicine , Indianapolis, IN, USA.
authors.forename: Tatsuo
authors.initials: T
authors.lastname: Okui
authors.affiliation: Department of Anesthesia, Paul and Carole Stark Neurosciences Research Institute, Indiana University , Indianapolis, IN, USA.
authors.forename: Fletcher A
authors.initials: FA
authors.lastname: White